Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “End Stage Renal Disease and Kidney Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04013620
What this trial is testing

CNI Transient Replacement by Belatacept From 3 to 12 Months Post Transplantation in Patients With Early Graft Dysfunction

Who this might be right for
Chronic Kidney Failure
Nantes University Hospital 48
Not applicableStudy completedNCT01786525
What this trial is testing

House Calls and Decision Support: Improving Access to Live Donor Transplantation

Who this might be right for
Chronic Kidney DiseaseEnd-Stage Renal Disease
Beth Israel Deaconess Medical Center 109
Testing effectiveness (Phase 2)Study completedNCT01594424
What this trial is testing

A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation

Who this might be right for
End Stage Renal Disease (ESRD)
Cedars-Sinai Medical Center 10
Large-scale testing (Phase 3)Study completedNCT00000935
What this trial is testing

An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens

Who this might be right for
End-Stage Renal DiseaseKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableUnknownNCT04693325
What this trial is testing

PROlonged Ex-vivo Normothermic Machine PERfusion for Kidney Regeneration

Who this might be right for
End Stage Renal Disease
Leiden University Medical Center 18
Not applicableActive Not RecruitingNCT01760733
What this trial is testing

Improved Selection of Elderly (> 65 Years) for Kidney Transplantation

Who this might be right for
Quality of LifeEnd Stage Renal DiseaseEnd Stage Renal Failure on Dialysis
Sykehuset Telemark 289
Not applicableUnknownNCT02895425
What this trial is testing

Registry for End Stage Renal Failure

Who this might be right for
End Stage Renal Failure
Centre Hospitalier de Cayenne 1,000
Not applicableUnknownNCT04066855
What this trial is testing

Sclerostin and Vascular Calcification in CKD and Renal Transplant

Who this might be right for
Vascular CalcificationChronic Kidney Failure
Ahmed Faisal Mohamed Mohamed Saleh 36
Post-approval studies (Phase 4)Study completedNCT00374803
What this trial is testing

Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal

Who this might be right for
End Stage Renal Disease (ESRD)
University of Cincinnati 45
Not applicableLooking for participantsNCT03803423
What this trial is testing

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

Who this might be right for
End Stage Renal DiseaseEnd Stage Liver Disease
Johns Hopkins University 1,000
Not applicableEnded earlyNCT03507348
What this trial is testing

Evaluation of Desensitization Protocols in HLA-incompatible Kidney-transplant Candidates

Who this might be right for
End-stage Renal DiseaseKidney TransplantationHla-incompatible Kidney Transplant Candidates
University Hospital, Grenoble 8
Not applicableNot Yet RecruitingNCT07379957
What this trial is testing

Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.

Who this might be right for
Kidney Transplantation
University Hospital, Bordeaux 450
Testing effectiveness (Phase 2)Ended earlyNCT00472082
What this trial is testing

Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationChronic Kidney Failure
Emory University 5
Not applicableStudy completedNCT01496417
What this trial is testing

Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores

Who this might be right for
End-Stage Renal Disease
University of Maryland 20
Very early researchLooking for participantsNCT07350837
What this trial is testing

CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants

Who this might be right for
Highly Sensitized Patients Awaiting Kidney Transplant
Tongji Hospital 12
Not applicableStudy completedNCT01976390
What this trial is testing

Comparing Everolimus and Sirolimus in Renal Transplant Recipients

Who this might be right for
Renal Failure
Ohio State University 60
Testing effectiveness (Phase 2)Study completedNCT01178216
What this trial is testing

Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation

Who this might be right for
End Stage Renal Disease
Stanley Jordan, MD 41
Not applicableStudy completedNCT06320730
What this trial is testing

Impact of Glycemic Control After Reperfusion on Acute Kidney Injury in Living Donor Liver Transplantation

Who this might be right for
Acute Kidney InjuryHyperglycemiaHypoglycemia+1 more
Asan Medical Center 3,790
Not applicableStudy completedNCT00805038
What this trial is testing

Transplant Navigator Intervention to Overcome Barriers to Kidney Transplantation

Who this might be right for
End Stage Renal Disease
Case Western Reserve University 167
Not applicableEnded earlyNCT01609673
What this trial is testing

Study of Everolimus in de Novo Renal Transplant Recipients

Who this might be right for
End Stage Renal Failure With Renal Transplant
Helady Pinheiro, MD, PhD 1
Next Page